(Reuters) - German researchers have enabled mice paralyzed after spinal cord injuries to walk again, re-establishing a neural link hitherto considered irreparable in mammals by using a designer protein injected into the brain.
PTC Therapeutics Inc is now accepting applications for the 2021 STRIVE Awards Program for Duchenne muscular dystrophy. The deadline to apply is March 15. Winners will be announced in September 2021.
Go inside the community simulation environment of Realistic Environment Applied Learning (REAL) therapy and learn how functional, task-specific treatment improves service delivery and patient outcomes. By Tracie Hunnicutt, MS, CCC-SLP; Julie Clement, OTR; and Susan Adix, PT.
A study of people with amputations who used a bionic hand for over one year highlights future challenges for developing realistic prosthetic devices. The study was published in Cell Reports.
When an athlete who uses a wheelchair rolls into a gym it can make coaches nervous about several different things. It doesn't have to be that way.
Dewpoint Therapeutics announces a new research collaboration with Pfizer for the development of potential therapeutics for the treatment of myotonic dystrophy type 1, DM1, a rare genetic disorder and one of two types of myotonic dystrophy.
DrySee introduces its patented waterproof bandage for low exudate wounds featuring liquid intrusion alert, designed to change the bandage's color if liquid breaches it and replacement is required.
Researchers saw a fourfold decline in the rate of patients who needed to go back to the hospital after total hip or knee replacements if they were enrolled in a program that used wearable step counters and conversational text messaging to keep tabs on recovery.
Almost 2 years into a research study conducted by Johns Hopkins APL and Johns Hopkins Medicine, a quadriplegic patient can now control two robotic arms with his brain — and can even feed himself, researchers share.